Skip to main content
Clinical Trials/EUCTR2018-003047-32-IT
EUCTR2018-003047-32-IT
Active, not recruiting
Phase 1

CardioPulmonary resuscitation with Argon (CPAr) trial - CPAR Trial

IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI0 sites50 target enrollmentMay 20, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cardiac Arrest
Sponsor
IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Enrollment
50
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI

Eligibility Criteria

Inclusion Criteria

  • 1\) witnessed non\-traumatic OHCA of presumably cardiac etiology with a presenting shockable rhythm; (2\) age \= 18 years; (3\) unconsciousness after return of spontaneous circulation (ROSC); (4\) duration of CPR \= 30 mins; (5\) initiation of study intervention \= 3 hrs from ROSC; (6\) stable SaO2 \= 94%, with a FiO2 of 30%.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 50
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 25

Exclusion Criteria

  • (1\) age \< 18 years; (2\) non\-witnessed CA; (3\) CA of traumatic origin; (4\) non\-presumably cardiac cause; (5\) non\-shockable presenting rhythm (pulseless electrical activity and asystole); (6\) pregnancy; (7\) known terminal illness; (8\) pre\-CA cerebral performance category (CPC) \= 3; (9\) initiation of the study intervention \> 3 hrs from ROSC; (10\) partecipation to another clinical trial;

Outcomes

Primary Outcomes

Not specified

Similar Trials